Carboxy terminal of β-amyloid deposits in aged human, canine, and polar bear brains

[1]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[2]  S. Younkin.  Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .

[3]  D. Mann,et al.  Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.

[4]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[5]  D. Mann,et al.  Dominant and differential deposition of distinct β-amyloid peptide species, Aβ N3(pE), in senile plaques , 1995, Neuron.

[6]  H. Vinters,et al.  Polyclonals to β-amyloid(1–42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum , 1994, Brain Research.

[7]  D. Price,et al.  Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. , 1994, The American journal of pathology.

[8]  H. Vinters,et al.  Monoclonal antibody to the C‐terminus of β‐amyloid , 1994 .

[9]  C. Soto,et al.  Structural Determinants of the Alzheimer's Amyloid β‐Peptide , 1994 .

[10]  P. Greengard,et al.  Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Price,et al.  Labeling of Cerebral Amyloid In Vivo with a Monoclonal Antibody , 1994, Journal of neuropathology and experimental neurology.

[12]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[13]  B T Hyman,et al.  Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. , 1994, The American journal of pathology.

[14]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[15]  T. Wisniewski,et al.  Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain , 1994, Neuroscience Letters.

[16]  Brian J Cummings,et al.  β-Amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease , 1993, Neurobiology of Aging.

[17]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[18]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Khadija Iqbal,et al.  Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. , 1993, Archives of biochemistry and biophysics.

[21]  M J Ball,et al.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.

[22]  W. Markesbery,et al.  Familial influence on plaque formation in the beagle brain. , 1992, Neuroreport.

[23]  H. Vinters.  Cerebral amyloid angiopathy and alzheimer's disease: two entities or one? , 1992, Journal of the Neurological Sciences.

[24]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[25]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[26]  Peter Davies,et al.  Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.

[27]  T. Umemura,et al.  Topographic relationship between senile plaques and cerebrovascular amyloidosis in the brain of aged dogs. , 1992, The Journal of veterinary medical science.

[28]  C. Cotman,et al.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.

[29]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[30]  C. Cotman,et al.  Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. , 1991, European journal of pharmacology.

[31]  T. Umemura,et al.  Modified Bielschowsky and immunohistochemical studies on senile plaques in aged dogs , 1991, Neuroscience Letters.

[32]  S. Little,et al.  Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. , 1991, Brain research. Molecular brain research.

[33]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[34]  B. Pollo,et al.  Cerebral preamyloid deposits and congophilic angiopathy in aged dogs , 1990, Neuroscience Letters.

[35]  D. Mann,et al.  EARLY SENILE PLAQUES IN DOWN'S SYNDROME BRAINS SHOW A CLOSE RELATIONSHIP WITH CELL BODIES OF NEURONS , 1989, Neuropathology and applied neurobiology.

[36]  K. Beyreuther,et al.  A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition , 1989, Journal of neuropathology and experimental neurology.

[37]  D. Mann,et al.  AN ANALYSIS OF THE MORPHOLOGY OF SENILE PLAQUES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES USING IMMUNOCYTOCHEMICAL AND LECTIN HISTOCHEMICAL TECHNIQUES , 1989, Neuropathology and applied neurobiology.

[38]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[39]  D. Price,et al.  Neurofibrillary Tangles and Senile Plaques in Aged Bears , 1988, Journal of neuropathology and experimental neurology.

[40]  D. Selkoe,et al.  Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.

[41]  C. Filley.  Diagnosis of Alzheimer's disease. , 1988, Colorado medicine.

[42]  S. Prusiner,et al.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[43]  D. Price,et al.  Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. , 1987, Science.

[44]  A. Hirano,et al.  A COMPARATIVE STUDY OF MODIFIED BIELSCHOWSKY, BODIAN AND THIOFLAVIN S STAINS ON ALZHEIMER'S NEUROFIBRILLARY TANGLES , 1986, Neuropathology and applied neurobiology.

[45]  S. Rapoport,et al.  Paucity of morphological changes in the brains of ageing beagle dogs: further evidence that alzheimer lesions are unique for primate central nervous system , 1983, Neurobiology of Aging.

[46]  T. Mandybur.  The incidence of cerebral amyloid angiopathy in Alzheimer's disease , 1975, Neurology.

[47]  H. Wiśniewski,et al.  Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[48]  C. Soto,et al.  Structural determinants of the Alzheimer's amyloid beta-peptide. , 1994, Journal of neurochemistry.

[49]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[50]  C. Abraham,et al.  Identification of full length β-amyloid precursor protein in human neuronal and non-neuronal cell culture supernatant: a possible extracellular source for the generation of Aβ , 1994 .

[51]  Brian J Cummings,et al.  Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. , 1993, Neurobiology of aging.

[52]  G. V. Van Hoesen,et al.  Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. , 1990, Progress in brain research.

[53]  Histochemistry Springer-Verlag.  A Histochemical and Ultrastructural Study , 1983 .

[54]  H. M. Zimmerman.  Progress in neuropathology , 1971 .